NVS - NOVARTIS AG
147.97
-3.020 -2.041%
Share volume: 2,117,536
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$150.99
-3.02
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | |
| Report Date | 04-23-2024 | 07-18-2024 | |
| Cash flow financing | -5.164 B | -3.200 B | |
| Other financing cash flows | 0.000 | 0.000 | |
| Cash flow | 2.265 B | 4.875 B | |
| Net income | 2.688 B | 3.246 B | |
| Depreciation | 1.342 B | 1.140 B | |
| Changes in inventories | 5.743 B | 5.747 B | |
| Changes in receivables | 8.251 B | 8.480 B | |
| Investing Cashflow | -899.000 M | -3.207 B | |
| Net Borrowings | 14.831 B | 17.521 B | |
| Investing Activity Other | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | |
| Capital Expenditures | -1.156 B | -728.000 M | |
| Cash Change | 9.694 B | 8.435 B |